MedPath

Attention Control Training (ACT) in PTSD patients: a randomized controlled trial.

Conditions
PTSD
Registration Number
NL-OMON29598
Lead Sponsor
one.
Brief Summary

none

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
66
Inclusion Criteria

Participants are admitted if PTSD has been determined in the intake with the help of the PCL-5 and LEC-5 and clinical judgment according to the DSM-5.

Exclusion Criteria

The exclusion criteria are:
1) psychotic or bipolar disorder
2) nonfluent Dutch
3) inability to use a computer keyboard
4) current psychotherapy
5) use of psychotropic medication that started within the past year. Participants will be removed from the study if their medication has to be changed during the trial. They will be admitted if they have been taking a stable dose of medication for at least 1 year.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The most important primary research variable is the decrease in PTSD symptomatology between the experimental group and the control group. We use the PCL-5 to measure this.
Secondary Outcome Measures
NameTimeMethod
The secondary research variables are the differences in general well-being; degree of aggression and quality of life between the experimental group and the control group. We use the PHQ-4, Buss-Perry and ORS questionnaires for this.
© Copyright 2025. All Rights Reserved by MedPath